Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review

INTRODUCTION: The epidermal growth factor receptor inhibitors (EGFRIs), cetuximab and panitumumab, represent an effective treatment option for patients affected by metastatic colorectal cancer (mCRC); furthermore, they are relatively devoid of systemic toxicities, which are commonly observed with st...

Descripción completa

Detalles Bibliográficos
Autores principales: Leporini, Christian, Saullo, Francesca, Filippelli, Gianfranco, Sorrentino, Antonio, Lucia, Maria, Perri, Gino, Gattuta, Gaetana La, Infusino, Stefania, Toscano, Rosa, Dima, Gianluca, Olivito, Virginia, Paletta, Laura, Bottoni, Ugo, De Sarro, Giovambattista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853676/
https://www.ncbi.nlm.nih.gov/pubmed/24347989
http://dx.doi.org/10.4103/0976-500X.120966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853676/
https://www.ncbi.nlm.nih.gov/pubmed/24347989
http://dx.doi.org/10.4103/0976-500X.120966

Ejemplares similares